$157.94 arrow  Change: 0.74 %Chge: 0.47% Vol: 48,816
End Of Day Prices
High: 159.41 | Low: 157.2 | Open: 157.68 | Close: 157.94
52 Wk High: 167.48 | 52 Wk Low: 80.14 | Todays Pivot: 158.18
Sector: Healthcare and Pharmaceuticals add stock to watch list

VRTX Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Merck 56.04 red arrow 772,525
Waters 112.8 red arrow 24,286
Steris 67.03 green arrow 23,481
Mylan 39.34 red arrow 395,013
Idexx Labs 89.11 red arrow 32,531
Illumina 189.56 green arrow 25,763
Dentsply Intl 39.2 red arrow 63,382
Quest Diagnostics 91.29 red arrow 37,408

Above is a small selection of related companies to Vertex Pharmaceuticals which compete alongside VRTX within the Healthcare and Pharmaceuticals sector. To see more related companies to VRTX, view our stock market today information page.

Online News For Vertex Pharmaceuticals

Vertex Pharmaceuticals (VRTX) Stock Rating Reaffirmed by JPMorgan Chase & Co

Aviva Plc bought 3,420 shares as the company's stock rose 33.61% with the market. Following the sale, the executive vice president now directly owns 46,202 shares of the company's stock, valued at approximately $7,346,118. The stock increased 0.50% or $0 ...

Vertex Pharmaceuticals Incorporated (VRTX) EVP Sells $336345.00 in Stock

1,880,425 shares of the company's stock traded hands. Following the completion of the sale, the chief executive officer now directly owns 176,747 shares of the company's stock, valued at approximately $27,747,511.53. Tekla Capital Management Llc who had ...

RPG, VRTX, CNC, PHM: Large Outflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Guggenheim S&P 500 Pure Growth ETF (Symbol: RPG) where we have detected an approximate $430.9 million dollar outflow -- that's ...

Vertex Pharmaceuticals Incorporated (VRTX) Position Increased by Cullinan Associates Inc

Finally, RBC Capital Markets reiterated a "buy" rating on shares of Vertex Pharmaceuticals in a report on Wednesday, October 12th. Rhenman & Partners Asset Management Ab who had been investing in Vertex Pharmaceuticals Inc for a number of months, seems to ...

Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $15.6 million of Shares

CEO & President of Vertex Pharmaceuticals Inc (VRTX) Jeffrey M Leiden sold 99,563 shares of VRTX on 01/16/2018 at an average price of $156.99 a share. The total sale was $15.6 million. Vertex Pharmaceuticals Inc is engaged in the business of discovering ...

Want To Add This Quote To Your Site?

With our stock widgets you can add a Vertex Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for VRTX to choose from. Visit here to build your stock quote widget »